CompuGroup Medical SE & Co. KGaA

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PMCUF has a market cap of 9.3B. Regarding current trading prices, CMPUY is priced at $23.00, while PMCUF trades at $89.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PMCUF's P/E ratio is 55.70. In terms of profitability, CMPUY's ROE is +0.01%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, CMPUY is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check PMCUF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MTHRY has a market cap of 5.9B. Regarding current trading prices, CMPUY is priced at $23.00, while MTHRY trades at $4.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MTHRY's P/E ratio is 19.26. In terms of profitability, CMPUY's ROE is +0.01%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, CMPUY and MTHRY have similar daily volatility (0.00).Check MTHRY's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MTHRF has a market cap of 5.7B. Regarding current trading prices, CMPUY is priced at $23.00, while MTHRF trades at $8.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MTHRF's P/E ratio is 18.59. In terms of profitability, CMPUY's ROE is +0.01%, compared to MTHRF's ROE of +0.17%. Regarding short-term risk, CMPUY is less volatile compared to MTHRF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MTHRF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PANHF has a market cap of 2.9B. Regarding current trading prices, CMPUY is priced at $23.00, while PANHF trades at $1.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PANHF's P/E ratio is 134.40. In terms of profitability, CMPUY's ROE is +0.01%, compared to PANHF's ROE of +0.04%. Regarding short-term risk, CMPUY and PANHF have similar daily volatility (0.00).Check PANHF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, CMPUY is priced at $23.00, while CMPVF trades at $33.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, CMPUY's ROE is +0.01%, compared to CMPVF's ROE of +0.01%. Regarding short-term risk, CMPUY is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CMPVF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PIAHY has a market cap of 1.6B. Regarding current trading prices, CMPUY is priced at $23.00, while PIAHY trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PIAHY's P/E ratio is 60.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to PIAHY's ROE of +0.04%. Regarding short-term risk, CMPUY is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check PIAHY's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, RSLBF has a market cap of 844.2M. Regarding current trading prices, CMPUY is priced at $23.00, while RSLBF trades at $24.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas RSLBF's P/E ratio is 34.68. In terms of profitability, CMPUY's ROE is +0.01%, compared to RSLBF's ROE of +0.24%. Regarding short-term risk, CMPUY and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CRWRF has a market cap of 828.5M. Regarding current trading prices, CMPUY is priced at $23.00, while CRWRF trades at $24.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, CMPUY is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CRWRF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, CMPUY is priced at $23.00, while SMSZF trades at $8.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, CMPUY's ROE is +0.01%, compared to SMSZF's ROE of -0.36%. Regarding short-term risk, CMPUY is less volatile compared to SMSZF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check SMSZF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, KSIOF has a market cap of 362.6M. Regarding current trading prices, CMPUY is priced at $23.00, while KSIOF trades at $3.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas KSIOF's P/E ratio is -378.58. In terms of profitability, CMPUY's ROE is +0.01%, compared to KSIOF's ROE of -0.13%. Regarding short-term risk, CMPUY is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check KSIOF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, VHIBF has a market cap of 328.9M. Regarding current trading prices, CMPUY is priced at $23.00, while VHIBF trades at $5.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas VHIBF's P/E ratio is 57.78. In terms of profitability, CMPUY's ROE is +0.01%, compared to VHIBF's ROE of +0.03%. Regarding short-term risk, CMPUY and VHIBF have similar daily volatility (0.00).Check VHIBF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, COGZF has a market cap of 289M. Regarding current trading prices, CMPUY is priced at $23.00, while COGZF trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas COGZF's P/E ratio is 28.17. In terms of profitability, CMPUY's ROE is +0.01%, compared to COGZF's ROE of +0.29%. Regarding short-term risk, CMPUY is less volatile compared to COGZF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check COGZF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, CMPUY is priced at $23.00, while SMDCF trades at $17.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, CMPUY's ROE is +0.01%, compared to SMDCF's ROE of N/A. Regarding short-term risk, CMPUY and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, CMPUY is priced at $23.00, while DLHTF trades at $3.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, CMPUY's ROE is +0.01%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, CMPUY and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, CMPUY is priced at $23.00, while VPAHF trades at $0.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, CMPUY and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, CMPUY is priced at $23.00, while SUSRF trades at $2.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, CMPUY's ROE is +0.01%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, CMPUY is less volatile compared to SUSRF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check SUSRF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, CMPUY is priced at $23.00, while ONVVF trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, CMPUY is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check ONVVF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, RVRC has a market cap of 101.4M. Regarding current trading prices, CMPUY is priced at $23.00, while RVRC trades at $1.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas RVRC's P/E ratio is -0.35. In terms of profitability, CMPUY's ROE is +0.01%, compared to RVRC's ROE of +0.07%. Regarding short-term risk, CMPUY and RVRC have similar daily volatility (0.00).Check RVRC's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, CMPUY is priced at $23.00, while CSAMF trades at $4.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, CMPUY's ROE is +0.01%, compared to CSAMF's ROE of -0.85%. Regarding short-term risk, CMPUY and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, TDMMF has a market cap of 56.2M. Regarding current trading prices, CMPUY is priced at $23.00, while TDMMF trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas TDMMF's P/E ratio is -7.97. In terms of profitability, CMPUY's ROE is +0.01%, compared to TDMMF's ROE of -0.24%. Regarding short-term risk, CMPUY is less volatile compared to TDMMF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check TDMMF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, CMPUY is priced at $23.00, while HITC trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas HITC's P/E ratio is -14.75. In terms of profitability, CMPUY's ROE is +0.01%, compared to HITC's ROE of -0.79%. Regarding short-term risk, CMPUY is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check HITC's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, CMPUY is priced at $23.00, while MDPEF trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to MDPEF's ROE of N/A. Regarding short-term risk, CMPUY and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, VASO has a market cap of 39.6M. Regarding current trading prices, CMPUY is priced at $23.00, while VASO trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas VASO's P/E ratio is 22.50. In terms of profitability, CMPUY's ROE is +0.01%, compared to VASO's ROE of +0.06%. Regarding short-term risk, CMPUY and VASO have similar daily volatility (0.00).Check VASO's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, EMOR has a market cap of 38.3M. Regarding current trading prices, CMPUY is priced at $23.00, while EMOR trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas EMOR's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to EMOR's ROE of +0.06%. Regarding short-term risk, CMPUY and EMOR have similar daily volatility (0.00).Check EMOR's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, CMPUY is priced at $23.00, while TREIF trades at $0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas TREIF's P/E ratio is -3.46. In terms of profitability, CMPUY's ROE is +0.01%, compared to TREIF's ROE of -1.90%. Regarding short-term risk, CMPUY is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check TREIF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CRVW has a market cap of 23.4M. Regarding current trading prices, CMPUY is priced at $23.00, while CRVW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CRVW's P/E ratio is -4.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to CRVW's ROE of +0.07%. Regarding short-term risk, CMPUY is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CRVW's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, CMPUY is priced at $23.00, while RTNXF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, CMPUY's ROE is +0.01%, compared to RTNXF's ROE of +75.44%. Regarding short-term risk, CMPUY is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check RTNXF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, CMPUY is priced at $23.00, while HDSLF trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, CMPUY's ROE is +0.01%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, CMPUY is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check HDSLF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, CMPUY is priced at $23.00, while THKKF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas THKKF's P/E ratio is -1.51. In terms of profitability, CMPUY's ROE is +0.01%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, CMPUY and THKKF have similar daily volatility (0.00).Check THKKF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, DGNOF has a market cap of 14.6M. Regarding current trading prices, CMPUY is priced at $23.00, while DGNOF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas DGNOF's P/E ratio is -3.59. In terms of profitability, CMPUY's ROE is +0.01%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, CMPUY is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check DGNOF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, CMPUY is priced at $23.00, while MNNDF trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, CMPUY's ROE is +0.01%, compared to MNNDF's ROE of N/A. Regarding short-term risk, CMPUY is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MNNDF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PBSV has a market cap of 12.4M. Regarding current trading prices, CMPUY is priced at $23.00, while PBSV trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PBSV's P/E ratio is -54.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, CMPUY and PBSV have similar daily volatility (0.00).Check PBSV's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, CMPUY is priced at $23.00, while CDXFF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, CMPUY's ROE is +0.01%, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, CMPUY and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, BRGX has a market cap of 8.7M. Regarding current trading prices, CMPUY is priced at $23.00, while BRGX trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas BRGX's P/E ratio is -0.90. In terms of profitability, CMPUY's ROE is +0.01%, compared to BRGX's ROE of +0.40%. Regarding short-term risk, CMPUY and BRGX have similar daily volatility (0.00).Check BRGX's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CMPD has a market cap of 8.7M. Regarding current trading prices, CMPUY is priced at $23.00, while CMPD trades at $6.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CMPD's P/E ratio is -15.70. In terms of profitability, CMPUY's ROE is +0.01%, compared to CMPD's ROE of -0.08%. Regarding short-term risk, CMPUY and CMPD have similar daily volatility (0.00).Check CMPD's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CMHSF has a market cap of 8.7M. Regarding current trading prices, CMPUY is priced at $23.00, while CMHSF trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CMHSF's P/E ratio is -3.23. In terms of profitability, CMPUY's ROE is +0.01%, compared to CMHSF's ROE of +0.41%. Regarding short-term risk, CMPUY and CMHSF have similar daily volatility (0.00).Check CMHSF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, CMPUY is priced at $23.00, while HBCNF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, CMPUY's ROE is +0.01%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, CMPUY is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check HBCNF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, CMPUY is priced at $23.00, while SPLTF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, CMPUY's ROE is +0.01%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, CMPUY is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check SPLTF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, CMPUY is priced at $23.00, while VYND trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas VYND's P/E ratio is -43.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to VYND's ROE of +0.81%. Regarding short-term risk, CMPUY and VYND have similar daily volatility (0.00).Check VYND's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, UDOCF has a market cap of 7.6M. Regarding current trading prices, CMPUY is priced at $23.00, while UDOCF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas UDOCF's P/E ratio is -2.93. In terms of profitability, CMPUY's ROE is +0.01%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, CMPUY is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check UDOCF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, AIMLF has a market cap of 7.4M. Regarding current trading prices, CMPUY is priced at $23.00, while AIMLF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas AIMLF's P/E ratio is -2.20. In terms of profitability, CMPUY's ROE is +0.01%, compared to AIMLF's ROE of -5.05%. Regarding short-term risk, CMPUY is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check AIMLF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, WLSS has a market cap of 6.9M. Regarding current trading prices, CMPUY is priced at $23.00, while WLSS trades at $2.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas WLSS's P/E ratio is -249.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, CMPUY is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check WLSS's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, CMPUY is priced at $23.00, while CRBKF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, CMPUY's ROE is +0.01%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, CMPUY and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, CMPUY is priced at $23.00, while DOCRF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, CMPUY's ROE is +0.01%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, CMPUY and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, CMPUY is priced at $23.00, while IQAIF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas IQAIF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, CMPUY is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check IQAIF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, CMPUY is priced at $23.00, while CBDS trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CBDS's P/E ratio is -1.49. In terms of profitability, CMPUY's ROE is +0.01%, compared to CBDS's ROE of +1.34%. Regarding short-term risk, CMPUY is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CBDS's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, NDATF has a market cap of 3.3M. Regarding current trading prices, CMPUY is priced at $23.00, while NDATF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas NDATF's P/E ratio is -8.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, CMPUY is less volatile compared to NDATF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check NDATF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, CMPUY is priced at $23.00, while RQHTF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, CMPUY's ROE is +0.01%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, CMPUY and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, CMPUY is priced at $23.00, while RYAHF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, CMPUY's ROE is +0.01%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, CMPUY and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, EBYH has a market cap of 1.9M. Regarding current trading prices, CMPUY is priced at $23.00, while EBYH trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas EBYH's P/E ratio is -5.42. In terms of profitability, CMPUY's ROE is +0.01%, compared to EBYH's ROE of +0.14%. Regarding short-term risk, CMPUY is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check EBYH's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, CMPUY is priced at $23.00, while MDBIF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MDBIF's P/E ratio is -0.26. In terms of profitability, CMPUY's ROE is +0.01%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, CMPUY is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MDBIF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MDXL has a market cap of 1.2M. Regarding current trading prices, CMPUY is priced at $23.00, while MDXL trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MDXL's P/E ratio is -0.28. In terms of profitability, CMPUY's ROE is +0.01%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, CMPUY is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MDXL's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, EVAHF has a market cap of 1M. Regarding current trading prices, CMPUY is priced at $23.00, while EVAHF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas EVAHF's P/E ratio is -0.42. In terms of profitability, CMPUY's ROE is +0.01%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, CMPUY and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, CMPUY is priced at $23.00, while EKGGF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas EKGGF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to EKGGF's ROE of +1.03%. Regarding short-term risk, CMPUY is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check EKGGF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CSOC has a market cap of 857.8K. Regarding current trading prices, CMPUY is priced at $23.00, while CSOC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CSOC's P/E ratio is 0.16. In terms of profitability, CMPUY's ROE is +0.01%, compared to CSOC's ROE of -4.64%. Regarding short-term risk, CMPUY and CSOC have similar daily volatility (0.00).Check CSOC's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MDRM has a market cap of 765.3K. Regarding current trading prices, CMPUY is priced at $23.00, while MDRM trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MDRM's P/E ratio is -0.60. In terms of profitability, CMPUY's ROE is +0.01%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, CMPUY is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MDRM's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MITI has a market cap of 550.2K. Regarding current trading prices, CMPUY is priced at $23.00, while MITI trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MITI's P/E ratio is -0.37. In terms of profitability, CMPUY's ROE is +0.01%, compared to MITI's ROE of -0.02%. Regarding short-term risk, CMPUY is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MITI's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, CMPUY is priced at $23.00, while MDNWF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, CMPUY's ROE is +0.01%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, CMPUY is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check MDNWF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PPJE has a market cap of 445.2K. Regarding current trading prices, CMPUY is priced at $23.00, while PPJE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PPJE's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, CMPUY and PPJE have similar daily volatility (0.00).Check PPJE's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, CMPUY is priced at $23.00, while CTVEF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, CMPUY's ROE is +0.01%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, CMPUY is less volatile compared to CTVEF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CTVEF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, CMPUY is priced at $23.00, while ACHKF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, CMPUY's ROE is +0.01%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, CMPUY and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, LVCE has a market cap of 357.2K. Regarding current trading prices, CMPUY is priced at $23.00, while LVCE trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas LVCE's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to LVCE's ROE of N/A. Regarding short-term risk, CMPUY is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check LVCE's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, RSLT has a market cap of 347.5K. Regarding current trading prices, CMPUY is priced at $23.00, while RSLT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas RSLT's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to RSLT's ROE of N/A. Regarding short-term risk, CMPUY and RSLT have similar daily volatility (0.00).Check RSLT's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, CMPUY is priced at $23.00, while NHIQ trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, CMPUY is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check NHIQ's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, DTRK has a market cap of 242.8K. Regarding current trading prices, CMPUY is priced at $23.00, while DTRK trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas DTRK's P/E ratio is -4.75. In terms of profitability, CMPUY's ROE is +0.01%, compared to DTRK's ROE of +0.37%. Regarding short-term risk, CMPUY is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check DTRK's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, USPS has a market cap of 215.1K. Regarding current trading prices, CMPUY is priced at $23.00, while USPS trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas USPS's P/E ratio is -1.36. In terms of profitability, CMPUY's ROE is +0.01%, compared to USPS's ROE of +0.62%. Regarding short-term risk, CMPUY and USPS have similar daily volatility (0.00).Check USPS's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, EWLL has a market cap of 185.1K. Regarding current trading prices, CMPUY is priced at $23.00, while EWLL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas EWLL's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, CMPUY is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check EWLL's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, CMPUY is priced at $23.00, while ALDNF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ALDNF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, CMPUY and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, CMPUY is priced at $23.00, while TSTTF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, CMPUY's ROE is +0.01%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, CMPUY is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check TSTTF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, CMPUY is priced at $23.00, while EMYSF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas EMYSF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, CMPUY is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check EMYSF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, CMPUY is priced at $23.00, while DSOL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas DSOL's P/E ratio is -0.01. In terms of profitability, CMPUY's ROE is +0.01%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, CMPUY is less volatile compared to DSOL. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check DSOL's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, CMPUY is priced at $23.00, while NEWUF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, CMPUY's ROE is +0.01%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, CMPUY and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, CMPUY is priced at $23.00, while PASO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PASO's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to PASO's ROE of +6.20%. Regarding short-term risk, CMPUY and PASO have similar daily volatility (0.00).Check PASO's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, LFCOF has a market cap of 63.4K. Regarding current trading prices, CMPUY is priced at $23.00, while LFCOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, CMPUY's ROE is +0.01%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, CMPUY is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check LFCOF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, CMPUY is priced at $23.00, while REFG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas REFG's P/E ratio is -0.01. In terms of profitability, CMPUY's ROE is +0.01%, compared to REFG's ROE of +0.01%. Regarding short-term risk, CMPUY and REFG have similar daily volatility (0.00).Check REFG's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, CMPUY is priced at $23.00, while SOFE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas SOFE's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, CMPUY is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check SOFE's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, CMPUY is priced at $23.00, while HDVY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas HDVY's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, CMPUY and HDVY have similar daily volatility (0.00).Check HDVY's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, CMPUY is priced at $23.00, while IGRW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas IGRW's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, CMPUY is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check IGRW's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, CMPUY is priced at $23.00, while WMGR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas WMGR's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, CMPUY and WMGR have similar daily volatility (0.00).Check WMGR's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, CMPUY is priced at $23.00, while SSYNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to SSYNF's ROE of N/A. Regarding short-term risk, CMPUY and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ORHB has a market cap of 27.5K. Regarding current trading prices, CMPUY is priced at $23.00, while ORHB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ORHB's P/E ratio is -0.02. In terms of profitability, CMPUY's ROE is +0.01%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, CMPUY and ORHB have similar daily volatility (0.00).Check ORHB's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, CMPUY is priced at $23.00, while TTBLF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, CMPUY is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check TTBLF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, NMXS has a market cap of 26.4K. Regarding current trading prices, CMPUY is priced at $23.00, while NMXS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas NMXS's P/E ratio is -0.07. In terms of profitability, CMPUY's ROE is +0.01%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, CMPUY is less volatile compared to NMXS. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check NMXS's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, FDBH has a market cap of 25K. Regarding current trading prices, CMPUY is priced at $23.00, while FDBH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas FDBH's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, CMPUY is less volatile compared to FDBH. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check FDBH's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, CMPUY is priced at $23.00, while NHEL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas NHEL's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, CMPUY and NHEL have similar daily volatility (0.00).Check NHEL's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, CMPUY is priced at $23.00, while BNVIF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas BNVIF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, CMPUY is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check BNVIF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, CMPUY is priced at $23.00, while HLTT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas HLTT's P/E ratio is -0.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, CMPUY and HLTT have similar daily volatility (0.00).Check HLTT's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, CMPUY is priced at $23.00, while CGNSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CGNSF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, CMPUY is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CGNSF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, CMPUY is priced at $23.00, while MOSTQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, CMPUY's ROE is +0.01%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, CMPUY and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, CMPUY is priced at $23.00, while ACNV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ACNV's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, CMPUY and ACNV have similar daily volatility (0.00).Check ACNV's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, CMPUY is priced at $23.00, while AHGIF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas AHGIF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, CMPUY is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check AHGIF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, CMPUY is priced at $23.00, while BBLNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas BBLNF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, CMPUY and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, CMPUY is priced at $23.00, while ICCO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ICCO's P/E ratio is -0.01. In terms of profitability, CMPUY's ROE is +0.01%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, CMPUY is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check ICCO's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, HSCHF has a market cap of 1.2K. Regarding current trading prices, CMPUY is priced at $23.00, while HSCHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas HSCHF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, CMPUY and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, CMPUY is priced at $23.00, while PCYS trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas PCYS's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, CMPUY is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check PCYS's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, CMPUY is priced at $23.00, while CNONF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas CNONF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, CMPUY is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check CNONF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, CMPUY is priced at $23.00, while OLMM trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas OLMM's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, CMPUY is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check OLMM's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, CMPUY is priced at $23.00, while ETAOF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas ETAOF's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, CMPUY is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check ETAOF's competition here

CMPUY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CMPUY stands at 1.2B. In comparison, LGBI has a market cap of 50. Regarding current trading prices, CMPUY is priced at $23.00, while LGBI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CMPUY currently has a P/E ratio of 38.98, whereas LGBI's P/E ratio is N/A. In terms of profitability, CMPUY's ROE is +0.01%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, CMPUY is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for CMPUY.Check LGBI's competition here